×

BioCorRx to Present at 10th Annual Singular Research Investor Conference on September 17, 2015

Los Angeles, Sept. 10, 2015 (GLOBE NEWSWIRE) -- BioCorRx, Inc. (OTCQX: BICX), developer of the Start Fresh Program, a Medication-Assisted Treatment (MAT) program, today announced that Brady Granier, Interim Chief Executive Officer, will present at the 10th Annual Singular Research Best of the Uncovereds Investor Conference being held on September 17, 2015 in Los Angeles.

Event: Singular Research 10th Annual Best of the Uncovereds Investor Conference
Date: Thursday, September 17, 2015
Time: 4:30 pm - 5:00 p.m. PT, Pacific Track
Location: Luxe Sunset Boulevard Hotel, 11461 Sunset Blvd., Los Angeles, CA 90049

Mr. Granier will be available for one-on-one meetings with investors participating in the conference. For those investors who would like to schedule an appointment, please contact Todd Markey by phone at 818-280-6800 or email at tmarkey@irpartnersinc.com or your Singular Research representative.

Visit BioCorRx, Inc.'s investor relations website www.BICXcorp.com to receive the most up to date company information.

Click here to view Recent National Television Media on the BioCorRx YouTube Channel

Click here for company Facebook page for more stories and media coverage

About BioCorRx

BioCorRx, Inc. (R) (BICX) is an addiction treatment and rehabilitation company offering a unique approach to the treatment of substance abuse addiction. The Start Fresh Program(R), a Medication-Assisted Treatment (MAT) program, consists of two components. The first component of the program consists of an outpatient implant procedure performed by a licensed physician. The implant delivers therapeutic levels of the drug Naltrexone, an opioid antagonist that significantly reduces physical cravings for alcohol and opioids, into the body. The second component of the program developed by BioCorRx, Inc. is a one on one counseling program specifically tailored for the treatment of alcoholism and other substance abuse addictions. Clinic reports show that the treatment program can be successful for individuals who complete the program. For more information on BICX, visit www.BioCorRx.com

Safe Harbor Statement

The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.

CONTACT: Investor Contact at BioCorRx: Press Contact at Singular Research: Todd Markey William Jones, CFA tmarkey@irpartnersinc.com wjones@singularresearch.com Phone: 818-280-6800 Phone: 267-987-2082

Source:BioCorRx